Tradestie Institutional Equity Comparison Engine

MRK vs UNOV โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

MRK Overall Edge

MRK Captures Institutional Edge (4โ€“0 Pillars ยท 7โ€“3 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Merck & Co., Inc. (MRK) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, MRK trades at 16.1x Forward P/E with 35.2% operating margin (+4.7% YoY revenue) versus UNOV at N/M Forward P/E and N/A operating margin (N/A YoY). In options structure, MRK sits in CONSOLIDATION (46th %ile IV; Dealer Gamma Walls on Pro) against UNOV sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner MRK
MRK 16.1x vs UNOV N/M Fwd P/E
Growth & Margin Winner MRK
Op Margin 35.2% vs N/A ยท YoY +4.7% vs N/A
Momentum & Technical Winner MRK
1Y +55.5% vs +9.5% ยท 52W Pos 81% vs 84%
Options & Structure Winner MRK
CONSOLIDATION (46th %ile IV) vs UNCLASSIFIED (N/A IV)
MRK NYSE
Merck & Co., Inc.
Pharmaceutical Preparations
$144.46
-2.23% 1D
Market Cap $364.3B
1M Return -1.02%
1Y Return +55.45%
Forward P/E 16.1x
Unified AI Score
56.6 / 100 HOLD
Tech 47.0 Fund 55.0 Flow 67.0 Mom 50.0
UNOV Cboe BZX
Innovator U.S. Equity Ultra Buffer ETF - November
Pharmaceutical Preparations
$41.13
-0.95% 1D
Market Cap N/A
1M Return -0.97%
1Y Return +9.53%
Forward P/E N/M
Unified AI Score
58.7 / 100 HOLD
Tech 48.0 Fund 60.0 Flow 50.0 Mom 50.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: MRK +55.45% UNOV +9.53% Spread: +45.92 pp (MRK Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
MRK TTM Op. Margin: 35.2% UNOV TTM Op. Margin: N/A
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on MRK vs UNOV. Trailing 12-month operating profitability (MRK 35.2% vs UNOV N/A) and valuation multiples (MRK 16.1x vs UNOV N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: MRK (7) vs UNOV (3)
Institutional Metric MRK UNOV Criterion Row Winner
Market Capitalization Scale $364.3B N/A Larger Scale MRK
Trailing P/E Ratio Valuation 147.8x N/M Lower Multiple MRK
Forward P/E Ratio Valuation 16.1x N/M Lower Multiple MRK
Revenue Growth (YoY) Growth +4.7% N/A Higher Growth MRK
Operating Margin (TTM) Profitability 35.2% N/A Higher Margin MRK
Net Profit Margin Profitability 3.6% N/A Higher Margin MRK
Return on Equity (ROE) Capital Efficiency 5.1% N/A Higher ROE MRK
52-Week Range Position Momentum 81% ($91โ€“$157) 84% ($37โ€“$42) Stronger Trend UNOV
Beta / 30D Volatility Risk Regime 0.20ฮฒ ยท 32% Vol 0.46ฮฒ ยท 11% Vol Lower Realized Risk UNOV
Unified Institutional Score Composite Signal 56.6 / 100 (HOLD) 58.7 / 100 (HOLD) Higher Composite UNOV

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full MRK vs UNOV Buy Guide
MRK CONSOLIDATION
58d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 46th %ile
IV Regime Balanced (25thโ€“60th %ile)
Live MRK Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
UNOV UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live UNOV Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither MRK nor UNOV registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.